Herbalife beats by $0.03, beats on revs; guides Q1 EPS below two analyst estimate; guides FY17 EPS below two analyst estimate, reaffirms FY17 revs guidance
- Reports Q4 (Dec) earnings of $1.00 per share, $0.03 better than the two analyst estimate of $0.97; revenues fell 4.8% year/year to $1.04 bln vs the $1.03 bln single analyst estimate.
- Guided Q4 volume at low end of -1.5% to +2.5% guidance, rev below previous guidance of down 2.5% to +1.5% due to FX headwind, reaffirmed EPS $0.80-1.00 on January 20.
- Co issues downside guidance for Q1, sees EPS of $0.75-0.95, excluding non-recurring items, vs. $1.29 two analyst; sales down 5-9%; volume down 1-5%.
- Co issues guidance for FY17, sees EPS of $3.65-4.05, excluding non-recurring items, vs. $5.00 two analyst estimate; sees FY17 revs of +0.3-3.3% to ~$4.62-4.64 bln vs. $4.55 bln two analyst est; volume up 2-5%.
- Company announces board approval of a new 3 year $1.5 billion share buyback program.